Especially when SURPASS-CVOT, showed tirzepatide failed to show superiority against Trulicity for major adverse cardiovascular events despite clear improvements in secondary cardiometabolic markers
Thats because curcumin can interfere with how these medications are broken down, potentially altering their effectiveness
It came into being in 2019
It contains the AC-3 peptide complex (glutamic acid and aspartic acid) designed to target hepatocyte gene expression for liver cell repair, bile production, and detoxification
Before the medication, I was truly living to eat
Potential risks include: Enhanced gastrointestinal side effects (nausea, vomiting, diarrhea, constipation) Increased risk of nutritional deficiencies and protein malnutrition Potential worsening of gastroesophageal reflux symptoms Dehydration risk and acute kidney injury, particularly during dose escalation Increased risk of gallbladder disease and complications Risk of intestinal obstruction or ileus Diabetic retinopathy progression in patients with diabetes, particularly with rapid glycemic improvement Hypoglycemia risk, particularly in patients on insulin or sulfonylureas Cost considerations and insurance coverage challenges Rare but serious risks including pancreatitis and thyroid C-cell tumors (boxed warning) Clinicians must engage in shared decision-making with patients, carefully weighing these potential benefits against risks in the context of individual patient circumstances, surgical outcomes, comorbidities, and treatment goals
